2017 annual financial data

UroGen Pharma 2017 Financial results

Direct answer

Revenue was 8,158,000 USD.

Operating income was -19,950,000 USD and net income was -20,000,000 USD.
Operating cash flow was -9,571,000 USD.

Get free UroGen Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
8,158,000 USD
Operating income
-19,950,000 USD
Net income
-20,000,000 USD
Operating cash flow
-9,571,000 USD